Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ann Arbor, MI
SEC filing record 1 source field available
Fiscal year end
31 December
Esperion Therapeutics, Inc. has filed 951 SEC EDGAR filings since 07 May 2008

SEC filing history

Showing 651-675 of 950 matching filings.

Per page
25
Current page
27
4

FORM 4 -

Filing date
09 Feb 2018
Reporting date
07 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87536

AMENDMENT NO. 2

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87536

SC 13G/A filing

Filing date
29 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87536

13D/A FILING SUBMITTED BY KERITH ON 1-29-18 FOR FILING ON SAME DAY. ISSUER IS ES

Filing date
29 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jan 2018
Reporting date
18 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87536

SC 13G/A filing

Filing date
03 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87536

SCHEDULE 13D/A

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
20 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
14 Dec 2017
Reporting date
14 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
14 Dec 2017
Reporting date
14 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 Dec 2017
Reporting date
05 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87536

FORM SC 13D/A FOR ESPERION THERAPEUTICS, INC. BY DOMAIN PARTNERS VII, L.P.

Filing date
08 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Dec 2017
Reporting date
06 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87536

SC 13G filing

Filing date
21 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
10 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-208701

424B5

Filing date
10 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-208701

424B5

Filing date
08 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .